{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:21:01Z","timestamp":1789597261039,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00787-015-0725-1","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T09:53:52Z","timestamp":1433152432000},"page":"1485-1496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial"],"prefix":"10.1007","volume":"24","author":[{"given":"Marie","family":"Stentebjerg-Olesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Ganocy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Findling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiki","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa P.","family":"DelBello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"issue":"1","key":"725_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1586\/14737175.4.1.53","volume":"4","author":"CM Young","year":"2004","unstructured":"Young CM, Findling RL (2004) Pharmacologic treatment of adolescent and child schizophrenia. Expert Rev Neurother 4(1):53\u201360","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"725_CR2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","volume":"16","author":"M Carbon","year":"2014","unstructured":"Carbon M, Correll CU (2014) Clinical predictors of therapeutic response to antipsychotics in schizophrenia. Dialogues Clin Neurosci 16(4):505\u2013524","journal-title":"Dialogues Clin Neurosci"},{"issue":"15","key":"725_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852900026213","volume":"S12","author":"PF Buckley","year":"2007","unstructured":"Buckley PF, Correll CU, Miller AL (2007) First-episode psychosis: a window of opportunity for best practices. CNS Spectr S12(15):1\u201312 discussion 13-4; quiz 15-6","journal-title":"CNS Spectr"},{"issue":"S4","key":"725_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852900026328","volume":"12","author":"JA Lieberman","year":"2007","unstructured":"Lieberman JA, Perkins DO, Jarskog LF (2007) Neuroprotection : a therappeutic strategy prevent deterioration associated with schizophrenia. CNS Spectr 12(S4):1\u201313","journal-title":"CNS Spectr"},{"key":"725_CR5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1192\/bjp.178.6.506","volume":"178","author":"G Harrison","year":"2001","unstructured":"Harrison G et al (2001) Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry 178:506\u2013517","journal-title":"Br J Psychiatry"},{"issue":"12","key":"725_CR6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","volume":"60","author":"O Agid","year":"2003","unstructured":"Agid O et al (2003) Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry 60(12):1228\u20131235","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"725_CR7","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1176\/appi.ajp.160.11.2063","volume":"160","author":"CU Correll","year":"2003","unstructured":"Correll CU et al (2003) Early prediction of antipsychotic response in schizophrenia. Am J Psychiatry 160(11):2063\u20132065","journal-title":"Am J Psychiatry"},{"issue":"3","key":"725_CR8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4088\/JCP.v68n0301","volume":"68","author":"S Leucht","year":"2007","unstructured":"Leucht S et al (2007) Early prediction of antipsychotic nonresponse among patients with schizophrenia. J Clin Psychiatry 68(3):352\u2013360","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"725_CR9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.schres.2008.01.018","volume":"101","author":"S Leucht","year":"2008","unstructured":"Leucht S et al (2008) Predicting antipsychotic drug response\u2014replication and extension to six weeks in an international olanzapine study. Schizophr Res 101(1\u20133):312\u2013319","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"725_CR10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.schres.2008.02.021","volume":"102","author":"BJ Kinon","year":"2008","unstructured":"Kinon BJ et al (2008) Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr Res 102(1\u20133):230\u2013240","journal-title":"Schizophr Res"},{"issue":"2","key":"725_CR11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/npp.2009.164","volume":"35","author":"BJ Kinon","year":"2010","unstructured":"Kinon BJ et al (2010) Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology 35(2):581\u2013590","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"725_CR12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/schbul\/sbm134","volume":"34","author":"H Ascher-Svanum","year":"2008","unstructured":"Ascher-Svanum H et al (2008) Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia. Schizophr Bull 34(6):1163\u20131171","journal-title":"Schizophr Bull"},{"key":"725_CR13","doi-asserted-by":"crossref","unstructured":"Samara MT, Leucht C, Leeflang MM, Anghelescu IG, Chung YC, Crespo-Facorro B, Elkis H, Hatta K, Giegling I, Kane JM, Kayo M, Lambert M, Lin CH, M\u00f6ller HJ, Pelayo-Teran JM, Riedel M, Serretti M, Zhao JJ, Correll CU, Leucht S (2015) Early improvement predicts later response to antipsychotics in schizophrenia: a diagnostic test review. Am J Psychiatry (in press)","DOI":"10.1176\/appi.ajp.2015.14101329"},{"key":"725_CR14","first-page":"10","volume":"18","author":"JE Overall","year":"1982","unstructured":"Overall JE, Pfefferbaum B (1982) The brief psychiatric rating scale for children. Psychopharmacol Bull 18:10\u201316","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"725_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261\u2013276","journal-title":"Schizophr Bull"},{"issue":"12","key":"725_CR16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.biopsych.2005.02.023","volume":"57","author":"S Leucht","year":"2005","unstructured":"Leucht S et al (2005) Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended. Biol Psychiatry 57(12):1543\u20131549","journal-title":"Biol Psychiatry"},{"issue":"2","key":"725_CR17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/JCP.0b013e3181d2193c","volume":"30","author":"EM Derks","year":"2010","unstructured":"Derks EM et al (2010) Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6\u00a0weeks of nonresponse? J Clin Psychopharmacol 30(2):176\u2013180","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"725_CR18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","volume":"163","author":"R Emsley","year":"2006","unstructured":"Emsley R, Rabinowitz J, Medori R (2006) Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry 163(4):743\u2013745","journal-title":"Am J Psychiatry"},{"issue":"12","key":"725_CR19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4088\/JCP.10m06349","volume":"72","author":"JA Gallego","year":"2011","unstructured":"Gallego JA et al (2011) Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months? J Clin Psychiatry 72(12):1691\u20131696","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"725_CR20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/01.jcp.0000246211.95905.8c","volume":"26","author":"YC Chang","year":"2006","unstructured":"Chang YC et al (2006) Optimizing early prediction for antipsychotic response in schizophrenia. J Clin Psychopharmacol 26(6):554\u2013559","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"725_CR21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1192\/bjp.bp.109.069328","volume":"196","author":"R Schennach-Wolff","year":"2010","unstructured":"Schennach-Wolff R et al (2010) An early improvement threshold to predict response and remission in first-episode schizophrenia. Br J Psychiatry 196(6):460\u2013466","journal-title":"Br J Psychiatry"},{"key":"725_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1741-7015-3-21","volume":"3","author":"H Liu-Seifert","year":"2005","unstructured":"Liu-Seifert H, Adams DH, Kinon BJ (2005) Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post hoc analysis of four atypical antipsychotic drugs. BMC Med 3:21","journal-title":"BMC Med"},{"issue":"11","key":"725_CR23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","volume":"165","author":"L Sikich","year":"2008","unstructured":"Sikich L et al (2008) Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry 165(11):1420\u20131431","journal-title":"Am J Psychiatry"},{"key":"725_CR24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-244X-12-150","volume":"12","author":"L Clemmensen","year":"2012","unstructured":"Clemmensen L, Vernal DL, Steinhausen HC (2012) A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry 12:150","journal-title":"BMC Psychiatry"},{"issue":"7","key":"725_CR25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaac.2013.04.018","volume":"52","author":"CU Correll","year":"2013","unstructured":"Correll CU et al (2013) Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes. J Am Acad Child Adolesc Psychiatry 52(7):689\u2013698.e3","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"725_CR26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/cap.2013.0007","volume":"23","author":"M Stentebjerg-Olesen","year":"2013","unstructured":"Stentebjerg-Olesen M et al (2013) Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics. J Child Adolesc Psychopharmacol 23(10):665\u2013675","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"725_CR27","volume-title":"Clinical global impression ECDEU assessment manual for psychopharmacology, revised","author":"W Guy","year":"1976","unstructured":"Guy W (1976) Clinical global impression ECDEU assessment manual for psychopharmacology, revised. National Institute of Mental Health, Rockville"},{"issue":"1","key":"725_CR28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/CHI.0b013e3181900404","volume":"48","author":"L Kryzhanovskaya","year":"2009","unstructured":"Kryzhanovskaya L et al (2009) Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 48(1):60\u201370","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"725_CR29","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","volume":"36","author":"J Kaufman","year":"1997","unstructured":"Kaufman J et al (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980\u2013988","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"725_CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1176\/ajp.143.1.35","volume":"143","author":"SC Yudofsky","year":"1986","unstructured":"Yudofsky SC et al (1986) The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143(1):35\u201339","journal-title":"Am J Psychiatry"},{"key":"725_CR31","first-page":"793","volume":"2","author":"JM Landgraf","year":"1996","unstructured":"Landgraf JM, Abetz N (1996) Measuring health outcomes in pediatric populations; issues in psychometrics and application. Qual Life Pharmacoeco Clin Trials 2:793\u2013802","journal-title":"Qual Life Pharmacoeco Clin Trials"},{"key":"725_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","volume":"212","author":"GM Simpson","year":"1970","unstructured":"Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11\u201319","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"725_CR33","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","volume":"154","author":"TR Barnes","year":"1989","unstructured":"Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672\u2013676","journal-title":"Br J Psychiatry"},{"issue":"4","key":"725_CR34","first-page":"486","volume":"39","author":"NR Schooler","year":"1982","unstructured":"Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39(4):486\u2013487","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"725_CR35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen NC et al (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162(3):441\u2013449","journal-title":"Am J Psychiatry"},{"issue":"2","key":"725_CR36","first-page":"93","volume":"31","author":"O Agid","year":"2006","unstructured":"Agid O, Seeman P, Kapur S (2006) The \u201cdelayed onset\u201d of antipsychotic action\u2014an idea whose time has come and gone. J Psychiatry Neurosci 31(2):93\u2013100","journal-title":"J Psychiatry Neurosci"},{"issue":"11","key":"725_CR37","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.2008.07061035","volume":"165","author":"RL Findling","year":"2008","unstructured":"Findling RL et al (2008) A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry 165(11):1432\u20131441","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"725_CR38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.psychres.2010.11.017","volume":"187","author":"VL Stauffer","year":"2011","unstructured":"Stauffer VL et al (2011) Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Res 187(1\u20132):42\u201348","journal-title":"Psychiatry Res"},{"issue":"1\u20133","key":"725_CR39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2011.02.011","volume":"128","author":"K Hatta","year":"2011","unstructured":"Hatta K et al (2011) Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia. Schizophr Res 128(1\u20133):127\u2013135","journal-title":"Schizophr Res"},{"key":"725_CR40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","volume":"187","author":"S Leucht","year":"2005","unstructured":"Leucht S et al (2005) Clinical implications of brief psychiatric rating scale scores. Br J Psychiatry 187:366\u2013371","journal-title":"Br J Psychiatry"},{"issue":"1","key":"725_CR41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biopsych.2010.01.012","volume":"68","author":"SZ Levine","year":"2010","unstructured":"Levine SZ, Leucht S (2010) Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories. Biol Psychiatry 68(1):86\u201392","journal-title":"Biol Psychiatry"},{"issue":"1\u20133","key":"725_CR42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2012.05.004","volume":"139","author":"R Schennach","year":"2012","unstructured":"Schennach R et al (2012) Response trajectories in \u201creal-world\u201d naturalistically treated schizophrenia patients. Schizophr Res 139(1\u20133):218\u2013224","journal-title":"Schizophr Res"},{"issue":"2","key":"725_CR43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/acps.12135","volume":"129","author":"C Nordon","year":"2014","unstructured":"Nordon C et al (2014) Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study. Acta Psychiatr Scand 129(2):116\u2013125","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"725_CR44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0033291713000330","volume":"44","author":"JM Pelayo-Ter\u00e1n","year":"2014","unstructured":"Pelayo-Ter\u00e1n JM et al (2014) Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis. Psychol Med 44(1):37\u201350","journal-title":"Psychol Med"},{"key":"725_CR45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-244X-11-23","volume":"11","author":"SJ Ruberg","year":"2011","unstructured":"Ruberg SJ et al (2011) Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia. BMC Psychiatry 11:23","journal-title":"BMC Psychiatry"},{"issue":"5","key":"725_CR46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.euroneuro.2010.10.003","volume":"21","author":"R Schennach-Wolff","year":"2011","unstructured":"Schennach-Wolff R et al (2011) Predictors of response and remission in the acute treatment of first-episode schizophrenia patients\u2013is it all about early response? Eur Neuropsychopharmacol 21(5):370\u2013378","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"725_CR47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jpsychires.2006.05.002","volume":"41","author":"B Crespo-Facorro","year":"2007","unstructured":"Crespo-Facorro B et al (2007) Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables. J Psychiatr Res 41(8):659\u2013666","journal-title":"J Psychiatr Res"},{"issue":"11","key":"725_CR48","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4088\/JCP.v67n1106","volume":"67","author":"R Emsley","year":"2006","unstructured":"Emsley R et al (2006) Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 67(11):1707\u20131712","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"725_CR49","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jpsychires.2011.07.014","volume":"45","author":"R Schennach-Wolff","year":"2011","unstructured":"Schennach-Wolff R et al (2011) Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder. J Psychiatr Res 45(12):1639\u20131647","journal-title":"J Psychiatr Res"},{"issue":"10","key":"725_CR50","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4088\/JCP.v69n1008","volume":"69","author":"H Ascher-Svanum","year":"2008","unstructured":"Ascher-Svanum H et al (2008) Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study. J Clin Psychiatry 69(10):1580\u20131588","journal-title":"J Clin Psychiatry"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-015-0725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-015-0725-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-015-0725-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T11:20:19Z","timestamp":1652181619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-015-0725-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s00787-015-0725-1","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}